Keywords:
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The still underestimated problem of fungal diseases worldwide.Front Microbiol. 2019; 10: 214https://doi.org/10.3389/fmicb.2019.00214
- Recent trends in the epidemiology of fungal infections.Infect Dis Clin North Am. 2021; 35: 237-260https://doi.org/10.1016/j.idc.2021.03.001
- Climate change and the emergence of fungal pathogens.Plos Pathog. 2021; 17: e1009503https://doi.org/10.1371/journal.ppat.1009503
- Recognition of diagnostic gaps for laboratory diagnosis of fungal diseases: expert opinion from the fungal diagnostics laboratories consortium (FDLC).J Clin Microbiol. 2021; 59: e0178420https://doi.org/10.1128/JCM.01784-20
- Multicenter evaluation of a PCR-based digital microfluidics and electrochemical detection system for the rapid identification of 15 fungal pathogens directly from positive blood cultures.J Clin Microbiol. 2020; 58 (020966-e2119)
- Lateral flow assays.Essays Biochem. 2016; 60: 111-120https://doi.org/10.1042/EBC20150012
- Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast.Emerg Infect Dis. 2014; 20: 45-53https://doi.org/10.3201/eid2001.130906
- Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid.Clin Infect Dis. 2014; 58: 113-116https://doi.org/10.1093/cid/cit641
- Point of care cryptococcal antigen screening: pipetting finger-prick blood improves performance of immuno-mycologics lateral flow assay.J Acquir Immune Defic Syndr. 2018; 78: 574-578https://doi.org/10.1097/QAI.0000000000001721
- Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: a feasibility study in rural Lesotho.PLoS One. 2017; 12: e0183656https://doi.org/10.1371/journal.pone.0183656
- Evaluation of serum cryptococcal antigen testing using two novel semiquantitative lateral flow assays in persons with cryptococcal antigenemia.J Clin Microbiol. 2020; 58 (020466-e2119)https://doi.org/10.1128/JCM.02046-19
- Evaluation of the diagnostic performance of a semiquantitative cryptococcal antigen point-of-care assay among HIV-infected persons with cryptococcal meningitis.J Clin Microbiol. 2021; 59: e0086021https://doi.org/10.1128/JCM.00860-21
- Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.Clin Infect Dis. 2011; 53: 1019-1023https://doi.org/10.1093/cid/cir613
- Cryptococcal and Histoplasma antigen screening among people with human immunodeficiency virus in Ghana and comparative analysis of OIDx Histoplasma lateral flow assay and IMMY Histoplasma enzyme immunoassay.Open Forum Infect Dis. 2022; 9: ofac277https://doi.org/10.1093/ofid/ofac277
- Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS.Mycoses. 2020; 63: 139-144https://doi.org/10.1111/myc.13023
- Comparison of a novel rapid lateral flow assay to enzyme immunoassay results for early diagnosis of coccidioidomycosis.Clin Infect Dis. 2021; 73: e2746-e2753https://doi.org/10.1093/cid/ciaa1205
- Development of a gold nanoparticle-based lateral-flow immunoassay for Pneumocystis pneumonia serological diagnosis at point-of-care.Front Microbiol. 2019; 10: 2917https://doi.org/10.3389/fmicb.2019.02917
- Point-of-care diagnostics for invasive aspergillosis: nearing the finish line.Expert Rev Mol Diagn. 2020; 20: 1009-1017https://doi.org/10.1080/14737159.2020.1820864
- Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.J Clin Oncol. 1997; 15: 139-147https://doi.org/10.1200/JCO.1997.15.1.139
- False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experience.J Infect. 2007; 55: 201-202https://doi.org/10.1016/j.jinf.2006.11.015
- The Aspergillus lateral flow assay for the diagnosis of invasive aspergillosis: an update.Curr Fungal Infect Rep. 2020; 14: 378-383https://doi.org/10.1007/s12281-020-00409-z
- New concepts in diagnostics for invasive mycoses: non-culture-based methodologies.J Fungi (Basel). 2019; 5: E9https://doi.org/10.3390/jof5010009
- Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis.Clin Vaccin Immunol. 2009; 16: 1844-1846https://doi.org/10.1128/CVI.00268-09
- The performance of galactomannan in combination with 1,3-β-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: evidences from 13 studies.Diagn Microbiol Infect Dis. 2019; 93: 44-53https://doi.org/10.1016/j.diagmicrobio.2018.08.005
- Performance of the bronchoalveolar lavage fluid Aspergillus galactomannan lateral flow assay with cube reader for diagnosis of invasive pulmonary aspergillosis: a multicenter cohort study.Clin Infect Dis. 2021; 73: e1737-e1744https://doi.org/10.1093/cid/ciaa1281
- Performance of two commercial assays for the detection of serum Aspergillus galactomannan in non-neutropenic patients.J Fungi (Basel). 2022; 8: 741https://doi.org/10.3390/jof8070741
- Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.J Infect. 2018; 77: 235-241https://doi.org/10.1016/j.jinf.2018.05.001
- Evaluation of aspergillus-specific lateral-flow device test using serum and bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis.J Clin Microbiol. 2019; 57 (000955-e119)https://doi.org/10.1128/JCM.00095-19
- Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: a comparative multicenter study.Med Mycol. 2020; 58: 444-452https://doi.org/10.1093/mmy/myz079
- Evaluation of the Bio-Rad Geenius HIV-1/2 test as a confirmatory assay.J Clin Virol. 2014; 60: 399-401https://doi.org/10.1016/j.jcv.2014.04.025
- Urine antigen detection as an aid to diagnose invasive aspergillosis.Clin Infect Dis. 2018; 67: 1705-1711https://doi.org/10.1093/cid/ciy326
- Forty years of molecular diagnostics for infectious diseases.J Clin Microbiol. 2022; 19: e0244621https://doi.org/10.1128/jcm.02446-21
- Accurate detection of Streptococcus pyogenes at the point of care using the cobas liat strep A nucleic acid test.Clin Pediatr (Phila). 2017; 56: 1128-1134https://doi.org/10.1177/0009922816684602
- Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: a systematic review and meta-analysis.J Med Virol. 2021; 93: 4523-4531https://doi.org/10.1002/jmv.26994
- Clinical impact of the rapid molecular detection of RSV and influenza A and B viruses in the emergency department.PLoS One. 2022; 17: e0274222https://doi.org/10.1371/journal.pone.0274222
- A narrative review of nine commercial point of care influenza tests: an overview of methods, benefits, and drawbacks to rapid influenza diagnostic testing.J Osteopath Med. 2022; https://doi.org/10.1515/jom-2022-0065
- Detection of influenza A and B viruses and respiratory syncytial virus by use of clinical laboratory improvement amendments of 1988 (CLIA)-Waived point-of-care assays: a paradigm shift to molecular tests.J Clin Microbiol. 2018; 56 (003677-e418)https://doi.org/10.1128/JCM.00367-18
- Point-of-Care testing for sexually transmitted infections: a review of recent developments.Arch Pathol Lab Med. 2020; 144: 1344-1351https://doi.org/10.5858/arpa.2020-0118-RA
- LAMP diagnostics at the point-of-care: emerging trends and perspectives for the developer community.Expert Rev Mol Diagn. 2021; 21: 43-61https://doi.org/10.1080/14737159.2021.1873769
- An overview of using fungal DNA for the diagnosis of invasive mycoses.Expert Rev Mol Diagn. 2022; 22: 169-184https://doi.org/10.1080/14737159.2022.2037423
- Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial.Clin Infect Dis. 2022; 75: 777-785https://doi.org/10.1093/cid/ciab1066
- Diagnostic performance of real-time polymerase chain reaction assay on blood for invasive aspergillosis and mucormycosis.Mycoses. 2021; 64: 1554-1562https://doi.org/10.1111/myc.13319
- Detection and identification of dermatophyte fungi in clinical samples using a commercial multiplex tandem PCR assay.Pathology. 2020; 52: 473-477https://doi.org/10.1016/j.pathol.2020.03.002
- Application of metagenomic next-generation sequencing in the diagnosis of pulmonary invasive fungal disease.Front Cell Infect Microbiol. 2022; 12: 949505https://doi.org/10.3389/fcimb.2022.949505
- Evaluation of the BioFire Blood Culture Identification 2 panel and impact on patient management and antimicrobial stewardship.Pathology. 2021; 53: 889-895https://doi.org/10.1016/j.pathol.2021.02.016
- Diagnosing invasive candidiasis.J Clin Microbiol. 2018; 56: e01909-e01917https://doi.org/10.1128/JCM.01909-17
- Non-culture diagnostics for invasive candidiasis: promise and unintended consequences.J Fungi (Basel). 2018; 4: E27https://doi.org/10.3390/jof4010027
- T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.Clin Infect Dis. 2015; 60: 892-899https://doi.org/10.1093/cid/ciu959
- Detecting infections rapidly and easily for candidemia trial, Part 2 (DIRECT2): a prospective, multicenter study of the T2Candida panel.Clin Infect Dis. 2018; 66: 1678-1686https://doi.org/10.1093/cid/cix1095
- WHO fungal priority pathogens list to guide research, development and public health action.(Available at:) (Accessed October 25, 2022)
- Diagnosis of histoplasmosis using the MVista Histoplasma galactomannan antigen qualitative lateral flow-based immunoassay: a multicenter study.Open Forum Infect Dis. 2021; 8: ofab454https://doi.org/10.1093/ofid/ofab454
- JMM profile: loop-mediated isothermal amplification (LAMP): for the rapid detection of nucleic acid targets in resource-limited settings.J Med Microbiol. 2022; 71https://doi.org/10.1099/jmm.0.001522
- Detection of Microsporum canis and Trichophyton mentagrophytes by loop-mediated isothermal amplification (LAMP) and real-time quantitative PCR (qPCR) methods.Vet Dermatol. 2022; https://doi.org/10.1111/vde.13111
- Comparison of PneumID real-time PCR assay with Amplex eazyplex LAMP assay for laboratory diagnosis of Pneumocystis jirovecii Pneumonia.Med Mycol. 2022; : myac043https://doi.org/10.1093/mmy/myac043
- Simple and rapid detection Aspergillus fumigatus by loop-mediated isothermal amplification coupled with lateral flow biosensor assay.J Appl Microbiol. 2021; 131: 2351-2360https://doi.org/10.1111/jam.15092
- SMART-LAMP: a smartphone-operated handheld device for real-time colorimetric point-of-care diagnosis of infectious diseases via loop-mediated isothermal amplification.Biosensors (Basel). 2022; 12: 424https://doi.org/10.3390/bios12060424
Article info
Publication history
Published online: March 15, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
